Bethesda, MD - A small study from Japan entitled the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART) suggests that aggressive lipid-lowering therapy using a ...

Apo B tests are blood tests that measure the concentration of Apolipoprotein B in the blood, which carries cholesterol that ...

An acute reduction in total cholesterol of ≥65%, or in LDL cholesterol of ≥70%, during each procedure; An interval mean total cholesterol of <7 mmol/l or LDL cholesterol <6.5 mmol/l (or decreases of ...

The APH-19 trial enrolled a total of 46 patients 5 to 17 years of age with HoFH who had a mean LDL-C at baseline of 436 mg/dL. Lomitapide was associated with statistically significant reductions in ...

Seth Baum, MD: Diagnosing homozygous FH [familial hypercholesterolemia] is a little difficult, as is diagnosing heterozygous FH. That’s the case because there’s a very large spectrum of presentation, ...

Credit: Regeneron. Evinacumab is a fully-human monoclonal antibody that binds to and blocks the function of angiopoietin-like 3 (ANGPTL3). The Food and Drug Administration (FDA) has approved Evkeeza ® ...

Please provide your email address to receive an email when new articles are posted on . LDL reduction is the major focus in the primary and secondary prevention of atherosclerotic CVD. In August, the ...

Seth Baum, MD: Barriers to access is an issue that comes up throughout cardiology over the past, I would say, 6 years or 7 years. Ever since PCSK9 [proprotein convertase subtilisin/kexin type 9] ...

The Ohio State Wexner Medical Center is now offering a new treatment for patients suffering from extremely high cholesterol. This treatment is e… The Lantern is the independent, award-winning student ...

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Kaneka, a global leader ...